Brooks O'Neil
Stock Analyst at Lake Street
(1.23)
# 1,533
Out of 4,650 analysts
26
Total ratings
38.46%
Success rate
-11.39%
Average return
Main Sectors:
Stocks Rated by Brooks O'Neil
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HROW Harrow | Maintains: Buy | $45 → $55 | $46.55 | +18.15% | 3 | Oct 4, 2024 | |
| MODV ModivCare | Maintains: Buy | $50 → $30 | $15.48 | +93.80% | 2 | Sep 17, 2024 | |
| ATEC Alphatec Holdings | Maintains: Buy | $32 → $18 | $5.42 | +232.10% | 4 | Sep 3, 2024 | |
| ORGO Organogenesis Holdings | Initiates: Buy | $5 | $2.98 | +67.79% | 1 | Jun 28, 2024 | |
| SRDX Surmodics | Downgrades: Hold | $43 | $37.51 | +14.64% | 3 | May 29, 2024 | |
| TNDM Tandem Diabetes Care | Maintains: Buy | $60 → $75 | $32.93 | +127.76% | 1 | May 22, 2024 | |
| PIII P3 Health Partners | Maintains: Buy | $9 → $4.5 | $0.39 | +1,062.19% | 1 | Mar 14, 2024 | |
| MDXG MiMedx Group | Initiates: Buy | $12 | $5.81 | +106.54% | 1 | Mar 7, 2024 | |
| LMAT LeMaitre Vascular | Maintains: Buy | $65 → $75 | $90.41 | -17.04% | 1 | Aug 2, 2023 | |
| RCEL AVITA Medical | Maintains: Buy | $30 → $40 | $10.33 | +287.22% | 5 | Jul 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $26 | $22.88 | +13.64% | 2 | Feb 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $45 | $2.16 | +1,988.17% | 1 | Nov 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $11 | $2.25 | +388.89% | 1 | Apr 8, 2022 |
Harrow
Oct 4, 2024
Maintains: Buy
Price Target: $45 → $55
Current: $46.55
Upside: +18.15%
ModivCare
Sep 17, 2024
Maintains: Buy
Price Target: $50 → $30
Current: $15.48
Upside: +93.80%
Alphatec Holdings
Sep 3, 2024
Maintains: Buy
Price Target: $32 → $18
Current: $5.42
Upside: +232.10%
Organogenesis Holdings
Jun 28, 2024
Initiates: Buy
Price Target: $5
Current: $2.98
Upside: +67.79%
Surmodics
May 29, 2024
Downgrades: Hold
Price Target: $43
Current: $37.51
Upside: +14.64%
Tandem Diabetes Care
May 22, 2024
Maintains: Buy
Price Target: $60 → $75
Current: $32.93
Upside: +127.76%
P3 Health Partners
Mar 14, 2024
Maintains: Buy
Price Target: $9 → $4.5
Current: $0.39
Upside: +1,062.19%
MiMedx Group
Mar 7, 2024
Initiates: Buy
Price Target: $12
Current: $5.81
Upside: +106.54%
LeMaitre Vascular
Aug 2, 2023
Maintains: Buy
Price Target: $65 → $75
Current: $90.41
Upside: -17.04%
AVITA Medical
Jul 13, 2023
Maintains: Buy
Price Target: $30 → $40
Current: $10.33
Upside: +287.22%
Feb 15, 2023
Maintains: Buy
Price Target: $20 → $26
Current: $22.88
Upside: +13.64%
Nov 21, 2022
Assumes: Buy
Price Target: $45
Current: $2.16
Upside: +1,988.17%
Apr 8, 2022
Initiates: Buy
Price Target: $11
Current: $2.25
Upside: +388.89%